Orum Therapeutics (475830 KS)

Analysis

Health Care • South Korea

Orum Therapeutics, Inc. operates as a clinical stage biotech company. The Company develops cell-penetrating antibodies, biomedical therapy applications, and pharmaceuticals for cancer and immune diseases. Orum Therapeutics serves clients worldwide.

Refresh

Exchange Announcement • 08 Apr 2026 17:25

[Revised] Exercise of Stock Option

Exchange Announcement • 01 Apr 2026 17:56

Exercise of Stock Option

Exchange Announcement • 27 Mar 2026 18:34

Outcomes of Annual Meeting of Shareholders

Exchange Announcement • 26 Mar 2026 17:59

[Revised] Resolutions for Convocation of General Meeting of Shareholders

Exchange Announcement • 19 Mar 2026 19:04

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

[Revised] Exercise of Stock Option

Exercise of Stock Option

Outcomes of Annual Meeting of Shareholders

[Revised] Resolutions for Convocation of General Meeting of Shareholders

Submission of Audit Report